title: Rituximab and thalidomide combination therapy for Castleman disease.
authors.forename: Karthik
authors.initials: K
authors.lastname: Ramasamy
authors.forename: Shreyans
authors.initials: S
authors.lastname: Gandhi
authors.forename: Melinda
authors.initials: M
authors.lastname: Tenant-Flowers
authors.forename: Mansour
authors.initials: M
authors.lastname: Ceesay
authors.forename: Sophie
authors.initials: S
authors.lastname: Corderoy
authors.forename: Robert
authors.initials: R
authors.lastname: Marcus
authors.forename: Stephen
authors.initials: S
authors.lastname: Schey
mesh_terms: D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D005871:Castleman Disease / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D000069283:Rituximab; D013792:Thalidomide / Q000627:therapeutic use*
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D013792:Thalidomide